NASDAQ:LCAV - LCA-Vision Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Receive LCAV News and Ratings via Email

Sign-up to receive the latest news and ratings for LCAV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:LCAV
CUSIPN/A
Phone+1-513-7929292

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

LCA-Vision (NASDAQ:LCAV) Frequently Asked Questions

What is LCA-Vision's stock symbol?

LCA-Vision trades on the NASDAQ under the ticker symbol "LCAV."

How were LCA-Vision's earnings last quarter?

LCA-Vision Inc. (NASDAQ:LCAV) announced its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) EPS for the quarter, missing the Zacks' consensus estimate of $0.23 by $0.24. The healthcare company earned $25.53 million during the quarter, compared to analysts' expectations of $32.04 million. View LCA-Vision's Earnings History.

Has LCA-Vision been receiving favorable news coverage?

News stories about LCAV stock have been trending positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. LCA-Vision earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave news stories about the healthcare company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an impact on the stock's share price in the next few days.

What other stocks do shareholders of LCA-Vision own?

How do I buy shares of LCA-Vision?

Shares of LCAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LCA-Vision's official website?

The official website for LCA-Vision is http://www.lasikplus.com/.

How can I contact LCA-Vision?

LCA-Vision's mailing address is 7840 Montgomery Rd, CINCINNATI, OH 45236-4301, United States. The healthcare company can be reached via phone at +1-513-7929292.


MarketBeat Community Rating for LCA-Vision (NASDAQ LCAV)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  142
MarketBeat's community ratings are surveys of what our community members think about LCA-Vision and other stocks. Vote "Outperform" if you believe LCAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel